Rua Bioscience Limited — Earnings Release 2025

Mar 2, 2025

==> picture [112 x 58] intentionally omitted <==

Results announcement

==> picture [453 x 527] intentionally omitted <==

----- Start of picture text ----- Results for announcement to the marketName of issuer Rua Bioscience LimitedReporting Period 6 months to 31 December 2024Previous Reporting Period 6 months to 31 December 2023Currency NZDAmount (000s) Percentage changeRevenue from continuing operations $889 529%Total Revenue $889 529%Net profit/(loss) from continuing ($1,802) 83%operationsTotal net profit/(loss) ($1,802) 83%Interim/Final DividendAmount per Quoted Equity Security Not proposing to pay a dividendImputed amount per Quoted Equity Not ApplicableSecurityRecord Date Not ApplicableDividend Payment Date Not ApplicableCurrent period Prior comparable periodNet tangible assets per Quoted $0.02 $0.05Equity SecurityA brief explanation of any of the Refer unaudited interim financial statementsfigures above necessary to enablethe figures to be understoodAuthority for this announcementName of person authorised to makePaul Naskethis announcementContact person for thisPaul NaskeannouncementContact phone number +64 (21) 445 154Contact email address paul.naske@ruabio.comDate of release through MAP 28 February 2025----- End of picture text -----

Unaudited financial statements accompany this announcement.